HOME   News & Information   Advanced GMP Communication
Advanced GMP Communication
회사소개서 신청하기
GMP 컨설팅 의뢰하기
GMP 컨설팅 실적 다운로드
GMP교육 신청하기
제약기술 전문지 [팜텍] 정보 및 신청하기
home contact us site map BS Intranet
A-GMP소통 그룹 소개

Advanced GMP Communication Group (A-GCG / A-GMP소통 그룹)은 현재와 미래의 GMP에 대하여 관심이 있는 제약인 등으로 구성된 모임으로 주기적인 GMP 지식공유 세미나 등을 실시하고 있습니다. 이 모임은 목표는 다음과 같습니다.

  • 미래의 GMP를 국제 경쟁력있게 준비하자.
  • GMP 네트워크의 강화를 통하여 GMP 관련 기술의 공유를 실현하자.
  • 실제적인 GMP지식경영(지식공유)을 실현하자.

A-GMP소통 그룹 참여 방법

Advanced GMP Communication Group에 참여하고자 하시는 분은 아래의 연락처로 연락주시면 성심성의껏 참여 방법을 설명드리도록 하겠습니다. (다만, 본 모임의 참여조건은 본 모임의 규칙에 따릅니다).

  - gmp@biosupport.co.kr

A-GMP소통 그룹 활동 현황 및 계획 + 토론방
제목 PIC/S GMP Annex 1 무균의약품 제조(202209)
작성자 김경민
글정보 Hit : 149, Date : 2022/10/03 11:23
   PICS_GMP_Annex_1_무균의약품_제조_20220909_개정.pdf (993 KB), Download : 85

PIC/S GMP Annex 1 Manufacture of Sterile Medicinal Products(2022 9 발행) 개정발행되었습니다첨부를 참조하시기 바랍니다.

Publication of revised PIC/S Annex 1

The revised Annex 1 to the PIC/S GMP Guide on the manufacture of sterile products has been published and will enter into force on 25 August 2023, except for point 8.123 which is postponed until 25 August 2024. The date of entry into operation is aligned with that of the revised EU Annex 1, which is identical to PIC/S Annex 1 (with some very minor editorial differences).

The entry into force closes a long revision process, which has been driven jointly by PIC/S and the EMA Inspectors’ Working Group (IWG) on GMDP in close co-operation with the European Commission (EC) and the World Health Organization (WHO). This has been a best-in-class model of international co-operation between EC, EMA, WHO, and PIC/S.

Annex 1 was first published in 1971 based on a PIC/S recommendation to ensure the sterility of medicinal products for the benefits of patients. It has undergone a number of partial revisions since its publication. This is, however, the first full revision aiming at restructuring this Annex, adding clarity to the requirements on the sterile manufacturing of medicinal products and introducing the principles of Quality Risk Management to allow for the inclusion of new technologies and innovative processes.

PIC/S decided to establish a Working Group on Annex 1 at its Rome meeting on 15-16 May 2014. It was then merged with the EMA IWG Drafting Group with a view to jointly revise Annex 1. WHO also decided to join the revision process with a view to align Annex 1 to the WHO GMP Guide. The joint Working Group included representatives of the Competent Authorities of PIC/S and EEA as well as WHO. The Working Group was first chaired by Andrew Hopkins (UK / MHRA) and then by Abdelaali Sarakha (France / ANSM).

Following two written consultations of Competent Authorities, the revision of Annex 1 was submitted to joint public consultation in December 2017. Over 6,300 comments were received during the 3-month consultation and then reviewed by the Working Group in 2018-19. This resulted into a new draft of the revised Annex 1, which was submitted to a second joint consultation from February to July 2020, during which approximately 2,000 comments were received and then reviewed by the Working Group in 2020-21.

The revised Annex 1 was then submitted to adoption to the EMA IWG on GMDP and the PIC/S Committee on 1 March and 29 April 2022, respectively. It has then been published by the EC on Eudralex and by PIC/S on the PIC/S website.


작성자   비밀번호
답글 글쓰기
경기도 안양시 동안구 동편로 13번길 65 (관양동,넥스트아이빌딩)
copyrightⓒ 2015 Bio-Support. All rights reserved.